Facephi Biometria (FACE) H1 2026 earnings summary

Executive summary

• H1 revenue was €11.575m, down 8.2% YoY, while net loss widened to €6.106m from €5.261m.

• LTM to June 2026 revenue was €34.942m, normalized EBITDA €9.408m and free cash flow €1.109m; positive LTM FCF was a first in the business’s history.

• SaaS exceeded 90% of the business as contracts shifted from prepaid multi-year terms toward post-consumption arrangements.

Financial highlights

• H1 operating loss was €5.261m versus €3.075m YoY; loss before tax was €6.112m versus €5.140m.

• H1 operating cash flow was €1.764m versus €0.584m; cash flow before financing was negative €0.8m versus negative €4.5m.

• Cash and cash equivalents were €0.720m at June 30, 2026, versus €2.173m at Dec. 31, 2025.

• H1 estimated normalized EBITDA was negative €1.2m and FCF negative €0.7m; FY estimates were €7.4m and positive €0.875m.

Outlook and guidance

• FY 2026 guidance is €32.5m revenue, €7.4m normalized EBITDA at a 22.8% margin, and positive FCF of €0.875m.

• Revenue guidance was reset from €46m as post-consumption contract terms spread billing and revenue recognition across contract years.

• Management said H1 remained aligned with full-year estimates and seasonality; no formal 2027 guidance was given, with a target to return to double-digit growth.